Report summary
For University of Kentucky Department of Pharmaceutical Sciences in 2015-2026, the graph shows 95 visible PIs and 213 internal PI collaborations. The main research signal is Medicine as the leading field (26% of slots across 49 PIs; 49 labels), Molecular Biology as the leading subfield (16% of slots across 38 PIs; 38 labels), and Microbial Natural Products and Biosynthesis as the leading topic (3% of slots across 9 PIs; 9 labels). That is a healthy pattern, with enough links to reveal several interpretable groups rather than one undifferentiated component. The most prominent PIs by weighted works are Sylvie Garneau‐Tsodikova (56.3 weighted works; Antifungal resistance and susceptibility, Microbial Natural Products and Biosynthesis); Chang‐Guo Zhan (47.4 weighted works; Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases). The clearest collaboration lines are Chang‐Guo Zhan and Fang Zheng (56 shared works, weight 32.1). The strongest breakdown groups are group 1 with 10 PIs, 11 internal connections, weight 36.2, around Molecular Biology, Ecology, Physiology, led by B. Mark Evers, Peixuan Guo, Kyung Bo Kim; group 2 with 9 PIs, 9 internal connections, weight 23.4, around Cellular and Molecular Neuroscience, Molecular Biology, Neurology, led by Michael T. Bardo, Linda P. Dwoskin, Jill Turner.
